Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke University School of Medicine to explore the ...

Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug Administration (FDA) has implemented significant labeling changes for KYZATREX® (testosterone undecanoate) CIII capsules.

Evansville, Indiana - Domestic Supply has introduced Testosterone Undecanoate, a product intended to support muscle retention and performance in athletes. This product is designed ...

Equities research analysts at StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Free Report) in a research report issued on Tuesday. The brokerage set a “hold” rating on the ...

LOS ANGELES and NEW YORK,, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The highly anticipated Jones Healthcare and Technology Innovation Conference will take place on April 8-9, 2025, at The Venetian Resort in ...

KYZATREX is a controlled substance (CIII) because it contains testosterone. It is not known if KYZATREX is safe or effective in males younger than 18 years old. Improper use may affect bone growth in ...

High testosterone in women can cause symptoms such as unwanted facial hair, acne, irregular menstrual cycles, and hair loss. If you notice one or more of these symptoms, schedule an appointment with a ...

Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.

Table 01: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034 Table 02: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of ...

By Danielle Friedman Five years ago, when Dr. Risa Kagan offered testosterone to postmenopausal women whose sex drive had vanished, the Berkeley-based OB-GYN had few takers. Women were wary of ...

Testosterone undecanoate is under clinical development by Marius Pharmaceuticals and currently in Phase I for Male Infertility. According to GlobalData, Phase I drugs for Male Infertility does not ...